Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2,556,332
-
Total 13F shares
-
52,369,697
-
Share change
-
+3,651,537
-
Total reported value
-
$312,930,503
-
Put/Call ratio
-
39%
-
Price per share
-
$5.98
-
Number of holders
-
71
-
Value change
-
+$27,233,992
-
Number of buys
-
39
-
Number of sells
-
32
Institutional Holders of Aptose Biosciences Inc. - Common Shares as of Q1 2021
As of 31 Mar 2021,
Aptose Biosciences Inc. - Common Shares was held by
71 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,369,697 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, DRW Securities, LLC, Nantahala Capital Management, LLC, Cormorant Asset Management, LP, First Light Asset Management, LLC, PICTET ASSET MANAGEMENT LTD, EVENTIDE ASSET MANAGEMENT, LLC, Woodline Partners LP, Polar Capital Holdings Plc, and VR Adviser, LLC.
This page lists
71
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.